There is an unmet clinical need to develop new treatment modality simultaneously considering killing local bacteria, and suitable host-modulation to enhance therapeutic outcome by reducing the tissue damage and regenerate the damaged periodontal tissues. EaffoCare is now developing novel triple-functionality FIT-Gel as a triple-in-one solution for effective and affordable therapy for periodontitis.
The current treatment for periodontitis uses systemic or local drug delivery with conventional scaling and root planning may be successful to control infection but not capable of protecting the treated periodontal tissue from recurrence periodontitis. These products do not promote host-modulation to reduce destruction of periodontal tissue and regeneration of tissue from the further periodontitis.
FiT-Gel-Pro for moderate periodontitis | FiT-Gel-Adv for advanced periodontitis.
Disclaimer: The information shared in the document is provided by the startup. iTIC shall not be held responsible for the information shared by the startup.